Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Valsecchi

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Panminerva Medica|November 11, 2021
The effect of frailty on in-hospital and medium-term mortality of patients with COronaVIrus Disease-19: the FRACOVID studyPaola Rebora, Emanuele Focà, Andrea Salvatori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Clinical epidemiology of childhood cancer in Central America and Caribbean countriesM G Valsecchi, G Tognoni, M Bonilla, et al.
Leukemia|December 25, 2004
Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangementsM Lanciotti, C Dufour, L Corral, et al.
Neuro-Oncology|November 13, 2007
Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastomaGraziella Filippini, Chiara Falcone, Amerigo Boiardi, et al.
Leukemia|November 9, 2000
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study groupA Biondi, M G Valsecchi, T Seriu, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|April 18, 2000
Bone marrow transplantation for childhood hematological disorders: a global pediatric approach in a twelve year single center experienceC Uderzo, E Biagi, A Rovelli, et al.
Blood|June 16, 2005
Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemiaRonald W Stam, Monique L den Boer, Pauline Schneider, et al.
British Journal of Haematology|February 1, 1997
Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)C Uderzo, M G Valsecchi, A Balduzzi, et al.
The New England Journal of Medicine|April 26, 2023
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic LeukemiaInge M van der Sluis, Paola de Lorenzo, Rishi S Kotecha, et al.
The Pharmacogenomics Journal|December 9, 2015
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocolR Franca, P Rebora, N Bertorello, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Panminerva Medica|November 11, 2021
The effect of frailty on in-hospital and medium-term mortality of patients with COronaVIrus Disease-19: the FRACOVID studyPaola Rebora, Emanuele Focà, Andrea Salvatori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Clinical epidemiology of childhood cancer in Central America and Caribbean countriesM G Valsecchi, G Tognoni, M Bonilla, et al.
Leukemia|December 25, 2004
Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangementsM Lanciotti, C Dufour, L Corral, et al.
Neuro-Oncology|November 13, 2007
Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastomaGraziella Filippini, Chiara Falcone, Amerigo Boiardi, et al.
Leukemia|November 9, 2000
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study groupA Biondi, M G Valsecchi, T Seriu, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|April 18, 2000
Bone marrow transplantation for childhood hematological disorders: a global pediatric approach in a twelve year single center experienceC Uderzo, E Biagi, A Rovelli, et al.
Blood|June 16, 2005
Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemiaRonald W Stam, Monique L den Boer, Pauline Schneider, et al.
British Journal of Haematology|February 1, 1997
Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)C Uderzo, M G Valsecchi, A Balduzzi, et al.
The New England Journal of Medicine|April 26, 2023
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic LeukemiaInge M van der Sluis, Paola de Lorenzo, Rishi S Kotecha, et al.
The Pharmacogenomics Journal|December 9, 2015
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocolR Franca, P Rebora, N Bertorello, et al.
Pageof 11